UPROSERTIB

UNII:	ZXM835LQ5E
Type:	INGREDIENT SUBSTANCE
Formula:	C₁₈H₁₆Cl₂F₂N₄O₂
Preferred Substance Name:	UPROSERTIB
InChIKey:	AXTAPYRUEKNRBA-JTQLQIEISA-N
GSRS Full Record:	ZXM835LQ5E i

1047634-65-0
2-FURANCARBOXAMIDE, N-((1S)-2-AMINO-1-((3,4-DIFLUOROPHENYL)METHYL)ETHYL)-5-CHLORO-4-(4-CHLORO-1-METHYL-1H-PYRAZOL-5-YL)-
AKT INHIBITOR GSK-2141795
AKT INHIBITOR GSK2141795
GSK-2141795C
GSK2141795
GSK2141795C
N-[(1S)-1-(Aminomethyl)-2-(3,4-difluorophenyl)ethyl]-5-chloro-4-(4-chloro-1-methyl-1H-pyrazol-5-yl)furan-2-carboxamide
N-[(2S)-1-amino-3-(3,4-difluorophenyl)propan-2-yl]-5-chloro-4-(4-chloro-1-methylpyrazol-5-yl)furan-2-carboxamide
N-[(2S)-1-amino-3-(3,4-difluorophenyl)propan-2-yl]-5-chloro-4-(4-chloro-1-methylpyrazol-5-yl)furan-2-carboxamide
UPROSERTIB [USAN]
Uprosertib [WHO-DD]
uprosertib [INN]

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

UPROSERTIB

Synonyms and Mappings

Resources